Linus Pauling Institute

Köhler S, Carmody L, Vasilevsky N, Jacobsen JOB, Danis D, Gourdine J-P, Gargano M, Harris NL, Matentzoglu N, McMurry JA et al..  2019.  Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources.. Nucleic Acids Res. 47(D1):D1018-D1027.

Komatsu A, Yoshino T, Suzuki T, Nakamura T, Kanai T, Watanabe K.  2019.  Risk factors associated with pseudoaldosteronism in patients with chronic hepatitis: A retrospective cohort study.. Basic Clin Pharmacol Toxicol. 124(5):607-614.

Kopparapu PR, Pearce MC, Löhr CV, Duong C, Jang HSang, Tyavanagimatt S, O'Donnell EF, Nakshatri H, Kolluri SK.  2024.  Identification and Characterization of a Small Molecule Bcl-2 Functional Converter.. Cancer Res Commun. 4(3):634-644.

Kovacs M, Trias E, Varela V, Ibarburu S, Beckman JS, Moura IC, Hermine O, King PH, Si Y, Kwon Y et al..  2019.  CD34 Identifies a Subset of Proliferating Microglial Cells Associated with Degenerating Motor Neurons in ALS.. Int J Mol Sci. 20(16)

Krouskop T, van Rijswijk L.  1995.  Standardizing performance-based criteria for support surfaces.. Ostomy Wound Manage. 41(1):34-6,38,40-5.

Krueger SK, VanDyke JE, Williams DE, Hines RN.  2006.  The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines.. Drug Metab Rev. 38(1-2):139-47.

Krueger SK, Williams DE, Yueh M-F, Martin SR, Hines RN, Raucy JL, Dolphin CT, Shephard EA, Phillips IR.  2002.  Genetic polymorphisms of flavin-containing monooxygenase (FMO).. Drug Metab Rev. 34(3):523-32.

Krueger SK, Martin SR, Yueh M-F, Pereira CB, Williams DE.  2002.  Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein.. Drug Metab Dispos. 30(1):34-41.

Krueger SK, Henderson MC, Siddens LK, VanDyke JE, Benninghoff AD, P Karplus A, Furnes B, Schlenk D, Williams DE.  2009.  Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.. Drug Metab Dispos. 37(8):1785-91.

Kubglomsong S, Theerakulkait C, Reed RL, Yang L, Maier CS, Stevens JF.  2018.  Isolation and Identification of Tyrosinase-Inhibitory and Copper-Chelating Peptides from Hydrolyzed Rice-Bran-Derived Albumin.. J Agric Food Chem. 66(31):8346-8354.

Kuiper HC, Stevens JF.  2011.  LC-MS/MS quantitation of mercapturic acid conjugates of lipid peroxidation products as markers of oxidative stress.. Curr Protoc Toxicol. Chapter 17:Unit17.14.2.

Kuiper HC, Langsdorf BL, Miranda CL, Joss J, Jubert C, Mata JE, Stevens JF.  2010.  Quantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation study.. Free Radic Biol Med. 48(1):65-72.

Kuiper HC, Miranda CL, Sowell JD, Stevens JF.  2008.  Mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites are in vivo markers of oxidative stress.. J Biol Chem. 283(25):17131-8.

Kuiper HC, Bruno RS, Traber MG, Stevens JF.  2011.  Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans.. Free Radic Biol Med. 50(7):848-53.

Kulkarni NN, Takahashi T, Sanford JA, Tong Y, Gombart AF, Hinds B, Cheng JY, Gallo RL.  2020.  Innate Immune Dysfunction in Rosacea Promotes Photosensitivity and Vascular Adhesion Molecule Expression.. J Invest Dermatol. 140(3):645-655.e6.

Kulkarni NN, Takahashi T, Sanford JA, Tong Y, Gombart AF, Hinds B, Cheng JY, Gallo RL.  2020.  Innate Immune Dysfunction in Rosacea Promotes Photosensitivity and Vascular Adhesion Molecule Expression.. J Invest Dermatol. 140(3):645-655.e6.

Kundu P, Paraiso IL, Choi J, Miranda CL, Kioussi C, Maier CS, Bobe G, Stevens JF, Raber J.  2022.  Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet.. Dis Model Mech. 15(11)

Kundu P, Holden S, Paraiso IL, Sudhakar R, McQuesten C, Choi J, Miranda CL, Maier CS, Bobe G, Stevens JF et al..  2022.  ApoE isoform-dependent effects of xanthohumol on high fat diet-induced cognitive impairments and hippocampal metabolic pathways.. Front Pharmacol. 13:954980.

Kuo MTH, Beckman JS, Shaw CA.  2019.  Neuroprotective effect of CuATSM on neurotoxin-induced motor neuron loss in an ALS mouse model.. Neurobiol Dis. 130:104495.

Kuschner CE, Choi J, Yin T, Shinozaki K, Becker LB, Lampe JW, Kim J.  2018.  Comparing phospholipid profiles of mitochondria and whole tissue: Higher PUFA content in mitochondria is driven by increased phosphatidylcholine unsaturation.. J Chromatogr B Analyt Technol Biomed Life Sci. 1093-1094:147-157.

Lande C, Rao S, Morré JT, Galindo G, Kirby J, Reardon PN, Bobe G, Stevens JFrederik.  2019.  Linden (Tilia cordata) associated bumble bee mortality: Metabolomic analysis of nectar and bee muscle.. PLoS One. 14(7):e0218406.

Langley BO, Ryan JJoan, Hanes D, Phipps J, Stack E, Metz TO, J Stevens F, Bradley R.  2021.  Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial.. Mol Nutr Food Res. 65(8):e2001170.

Langley BO, Ryan JJoan, Phipps J, Buttolph L, Bray B, Aslan JE, Metz TO, Stevens JF, Bradley R.  2022.  Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.. Trials. 23(1):885.

Larkin A, Williams DE, Kile ML, Baird WM.  2015.  Developing a smartphone software package for predicting atmospheric pollutant concentrations at mobile locations.. Comput J. 58(6):1431-1442.

Larsen CA, Dashwood RH.  2010.  (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells.. Arch Biochem Biophys. 501(1):52-7.